C07C 62/34
Containing ether groups, [image cpc-sch-c07c-0958.gif] groups,[image cpc-sch-c07c-0959.gif] groups, or[image cpc-sch-c07c-0960.gif] groups
Official title: containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups
C07C62/34 (Containing ether groups, [image cpc-sch-c07c-0958.gif] groups,[image cpc-sch-c07c-0959.gif] groups, or[image cpc-sch-c07c-0960.gif] groups) appears on 119 US grants and 58 published applications in this corpus.
Search patents in C07C- Granted patents
- 119
- Published applications
- 58
- Assignees
- 67
- Inventors
- 300
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 5 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 0 | 0 |
| 1985 | 5 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 9 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 1 |
| 2002 | 3 | 3 |
| 2003 | 1 | 1 |
| 2004 | 1 | 4 |
| 2005 | 1 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 3 |
| 2008 | 1 | 2 |
| 2009 | 3 | 0 |
| 2010 | 0 | 6 |
| 2011 | 4 | 4 |
| 2012 | 4 | 2 |
| 2013 | 2 | 2 |
| 2014 | 3 | 2 |
| 2015 | 1 | 4 |
| 2016 | 3 | 2 |
| 2017 | 1 | 5 |
| 2018 | 3 | 4 |
| 2019 | 3 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 2 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and compositions for treating conditions associated with LPA receptor activity30 Sep 2025US 12,428,375 B2Lhotse Bio, Inc.
- Compounds and compositions for treating conditions associated with LPA receptor activity30 Jan 2024US 11,884,627 B2Lhotse Bio, Inc.
- Carbon monoxide-releasing molecules triggered by physiological stimuli27 Jun 2023US 11,685,711 B2Georgia State University Research Foundation, Inc.
- Methods and compositions for treatment of cancer6 Jun 2023US 11,667,666 B2CFD Research Corporation
- Therapeutic compounds and methods of use thereof28 Sep 2021US 11,130,726 B2Genentech, Inc.
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Compounds and compositions for treating conditions associated with lpa receptor activity18 Jun 2026US 2026/0167607 A1Lhotse Bio, Inc.
- Compounds and compositions for treating conditions associated with lpa receptor activity14 Nov 2024US 2024/0376054 A1Lhotse Bio, Inc.
- Compounds and compositions for treating conditions associated with lpa receptor activity12 Oct 2023US 2023/0322675 A1Lhotse Bio, Inc.
- Therapeutic compounds and methods of use thereof24 Feb 2022US 2022/0055977 A1Genentech, Inc.
Most cited
By later US patents
- Prostaglandin receptor ligands35US 6,211,197 B1Merck Frosst Canada, Inc. · 2001
- Phenol derivatives24US 4,904,661 AImperial Chemical Industries PLC · 1990
- Phenyl azabicyclohexanones23US 4,118,393 AAmerican Cyanamid Company · 1978
- Phenanthrene derivatives20US 5,192,817 AOtsuka Pharmaceutical Co., Ltd. · 1993
- Endothelin receptor antagonists20US 5,817,693 A1998